about
A novel molecular diagnostic of glioblastomas: detection of an extracellular fragment of protein tyrosine phosphatase muProteolytic cleavage of protein tyrosine phosphatase mu regulates glioblastoma cell migrationGene therapy for brain tumors: basic developments and clinical implementationKnocking down SMC1A inhibits growth and leads to G2/M arrest in human glioma cellsMiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma.Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach.A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of Flt3L for glioma therapeuticsThe pathobiology of glioma tumorsStudy of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastoma.Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma.Inhibition of BET bromodomain targets genetically diverse glioblastomaIncreased nanoparticle-loaded exogenous macrophage migration into the brain following PDT-induced blood-brain barrier disruption.Association between the epidermal growth factor +61 G/A polymorphism and glioma risk: a meta-analysis.Fluoxetine, an antidepressant, suppresses glioblastoma by evoking AMPAR-mediated calcium-dependent apoptosis.SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy.Evaluation of combined bevacizumab plus irinotecan therapy in brain tumors using magnetic resonance imaging measures of relative cerebral blood volumeGlioblastoma multiforme: Molecular characterization and current treatment strategy (Review).Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signaturesThe involvement of xanthohumol in the expression of annexin in human malignant glioblastoma cells.Adenoviral virotherapy for malignant brain tumorsChallenges in cancer research and multifaceted approaches for cancer biomarker quest.A chimeric adenovirus with an Ad 3 fiber knob modification augments glioma virotherapy.Novel treatment strategies for malignant gliomas using neural stem cells.Signaling in malignant astrocytomas: role of neural stem cells and its therapeutic implications.Protein tyrosine phosphatases in glioma biologyRNA interference therapy for glioblastoma.Cancer-initiating enriched cell lines from human glioblastoma: preparing for drug discovery assays.Towards tailored therapy of glioblastoma multiforme.Novel approaches to glioma drug design and drug screening.Novel chemotherapeutics and other therapies for treating high-grade glioma.Implications of mitogen-activated protein kinase signaling in glioma.Biodegradable brain-penetrating DNA nanocomplexes and their use to treat malignant brain tumors.Activation of TRPM7 by naltriben enhances migration and invasion of glioblastoma cells.Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion.Xyloketal B suppresses glioblastoma cell proliferation and migration in vitro through inhibiting TRPM7-regulated PI3K/Akt and MEK/ERK signaling pathways.The impact of arsenic trioxide and all-trans retinoic acid on p53 R273H-codon mutant glioblastoma.Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cells.Concomitant treatment of F98 glioma cells with new liposomal platinum compounds and ionizing radiation.Glioblastoma treatment: bypassing the toxicity of platinum compounds by using liposomal formulation and increasing treatment efficiency with concomitant radiotherapy.
P2860
Q24608210-F16A5CD8-FA1D-4EB7-ABF7-7CE7F7D000CCQ24650562-C69AE46F-1202-4B32-8683-93D14A43C371Q26829086-0751BD6B-BB23-420F-AA3C-58461294DF12Q28611427-60EF00C3-FF63-4204-81ED-2F54476BE0C3Q33704269-44DB7C73-CDC0-4BFB-BC5D-FE2951D99B55Q33828114-3C4CC4C9-9C72-4C39-B7FC-0713807D6C46Q33864238-10A96BAE-A317-4B13-B440-70BFC89E3640Q33877450-39814CE5-23DD-477F-A659-504BF159A5CCQ33921072-95041569-B8AC-491E-95A0-96A7E8225A04Q34012284-F0CEEA85-2B49-4327-A1A8-1E473983BF02Q34110809-1F031B23-B023-434C-AB2B-2C57E2E23341Q34231228-B139DA17-6FF9-4954-B952-F5E4C174E433Q34987685-7CFB8741-B881-40FF-8DB5-220CE2721F49Q35150484-07AB7441-9C46-469A-A84A-DF33B1326F04Q35741615-A6489E32-BE6C-4CAA-8DF3-4DAED24BC683Q35828601-07F4A608-90C5-49BD-94B6-33976487212DQ35881632-BC5FC6E1-8AE2-47BB-9431-2339DE386403Q36225372-E5B16B72-C30C-4950-9865-D7C906582395Q36268697-BA124399-0671-4029-AA63-384B91C8A603Q36599915-98E662A3-A98E-4CFF-82CF-A6E65F6CF335Q37223846-A929222E-09F8-4E99-9003-B06F7A093551Q37425361-14EB0FFC-241A-4B79-A83B-E25CE6C9487CQ37475446-08DEA6B7-60A5-4428-A93C-8EE20F74B617Q37533630-F840007E-555C-4E72-BE06-DAC81E669727Q37637707-6C45DF61-B3AE-4406-BB8D-C354D923BA16Q37638344-4777905F-043F-4D01-8A28-A9E30385FC67Q37736499-A836C03F-D154-4DFB-AAC1-2D3175382C60Q37895975-C4102920-256F-4D6F-8D80-1D70AEF74AD1Q37908815-4F6B8F20-6B3B-4019-826E-0EE6577C3297Q38112184-F6F86EFF-A177-46B9-B1B8-67C72BFDAFC8Q38569802-0C484F83-2D15-410C-BF55-9860CE3EA5E4Q38618205-DAB590D2-3661-428E-91BE-C7D5F2872380Q38685603-C8766205-4048-408C-9981-89FB27706848Q38722636-98730C06-10DA-4FA5-96DF-33090ED53462Q38875988-09BB7426-B4BF-4A91-B154-4A6A1EAF67ADQ38882167-5D3AF403-F0B2-4A38-893C-A4C3C55556BAQ39036566-EDC6252F-C7E4-49F7-B55A-4237871766C3Q39354039-9B33856A-A565-498C-A1FB-802401E632E6Q39465147-A10AE3B9-88CD-404F-82B6-4FD1308B4FC8Q41807435-3515A3C1-DAE4-4DB8-8646-EAA6EE9FEB88
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Designer therapies for glioblastoma multiforme.
@en
Designer therapies for glioblastoma multiforme.
@nl
type
label
Designer therapies for glioblastoma multiforme.
@en
Designer therapies for glioblastoma multiforme.
@nl
prefLabel
Designer therapies for glioblastoma multiforme.
@en
Designer therapies for glioblastoma multiforme.
@nl
P2860
P356
P1476
Designer therapies for glioblastoma multiforme.
@en
P2093
Jeremy N Rich
Sith Sathornsumetee
P2860
P304
P356
10.1196/ANNALS.1444.009
P407
P577
2008-10-01T00:00:00Z